logo

Tiziana Life Sciences Plc (TLSA)



Trade TLSA now with
  Date
  Headline
9/2/2021 2:25:01 AM Precision BioSciences, Tiziana Life Sciences To Evaluate Foralumab With Allogeneic CAR T Candidates For Cancer Treatment
8/20/2021 3:53:32 AM Tiziana Life Sciences To Delist From LSE
6/23/2021 3:42:27 AM Tiziana Agrees With FHI Clinical To Conduct Phase 2 Clinical Trial For COVID-19 Patients With Intranasal Foralumab
6/21/2021 2:36:16 AM Tiziana Appoints Kevin Schutz As VP Of Regulatory Affairs
1/13/2021 2:34:13 AM Tiziana Life Sciences Appoints Neil Graham Chief Medical Officer
8/24/2020 3:07:05 AM Tiziana Granted Patent On Methods And Use Of Anti-IL-6/IL-6 Receptor Monoclonal Antibodies
6/29/2020 3:13:55 AM Tiziana Life Sciences Executes Agreement With STC Biologics For GMP Manufacturing Of TZLS-501
5/29/2020 2:13:54 AM Tiziana Life Sciences Says StemPrintER Outperforms Oncotype DX In Analysis With 800+ Samples
5/22/2020 2:26:05 AM Tiziana Lifesciences Intends To Demerge StemPrintER Genomics-Based Personalized Medicine Business As Separate Listed Co.